Plasma Exchange in Severe Attacks of Neuromyelitis Optica

Background. Neuromyelitis optica (NMO) attacks are poorly controlled by steroids and evolve in stepwise neurological impairments. Assuming the strong humoral response underlying NMO attacks, plasma exchange (PLEX) is an appropriate technique in severe NMO attacks. Objective. Presenting an up-to-date...

Full description

Bibliographic Details
Main Authors: Mickael Bonnan, Philippe Cabre
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Multiple Sclerosis International
Online Access:http://dx.doi.org/10.1155/2012/787630
id doaj-214a886073f7443cad605b301af6c62f
record_format Article
spelling doaj-214a886073f7443cad605b301af6c62f2020-11-24T23:58:36ZengHindawi LimitedMultiple Sclerosis International2090-26542090-26622012-01-01201210.1155/2012/787630787630Plasma Exchange in Severe Attacks of Neuromyelitis OpticaMickael Bonnan0Philippe Cabre1Service de Neurologie, Hopital F. Mitterand, 64000 Pau, FranceService de Neurologie, Hôpital Zobda Quitman, 97261 Fort de France, MartiniqueBackground. Neuromyelitis optica (NMO) attacks are poorly controlled by steroids and evolve in stepwise neurological impairments. Assuming the strong humoral response underlying NMO attacks, plasma exchange (PLEX) is an appropriate technique in severe NMO attacks. Objective. Presenting an up-to-date review of the literature of PLEX in NMO. Methods. We summarize the rationale of PLEX in relation with the physiology of NMO, the main technical aspects, and the available studies. Results. PLEX in severe attacks from myelitis or optic neuritis are associated with a better outcome, depending on PLEX delay (“time is cord and eyes”). NMO-IgG status has no influence. Finally, we build up an original concept linking the inner dynamic of the lesion, the timing of PLEX onset and the expected clinical results. Conclusion. PLEX is a safe and efficient add-on therapy in NMO, in synergy with steroids. Large therapeutic trials are required to definitely assess the procedure and define the time opportunity window.http://dx.doi.org/10.1155/2012/787630
collection DOAJ
language English
format Article
sources DOAJ
author Mickael Bonnan
Philippe Cabre
spellingShingle Mickael Bonnan
Philippe Cabre
Plasma Exchange in Severe Attacks of Neuromyelitis Optica
Multiple Sclerosis International
author_facet Mickael Bonnan
Philippe Cabre
author_sort Mickael Bonnan
title Plasma Exchange in Severe Attacks of Neuromyelitis Optica
title_short Plasma Exchange in Severe Attacks of Neuromyelitis Optica
title_full Plasma Exchange in Severe Attacks of Neuromyelitis Optica
title_fullStr Plasma Exchange in Severe Attacks of Neuromyelitis Optica
title_full_unstemmed Plasma Exchange in Severe Attacks of Neuromyelitis Optica
title_sort plasma exchange in severe attacks of neuromyelitis optica
publisher Hindawi Limited
series Multiple Sclerosis International
issn 2090-2654
2090-2662
publishDate 2012-01-01
description Background. Neuromyelitis optica (NMO) attacks are poorly controlled by steroids and evolve in stepwise neurological impairments. Assuming the strong humoral response underlying NMO attacks, plasma exchange (PLEX) is an appropriate technique in severe NMO attacks. Objective. Presenting an up-to-date review of the literature of PLEX in NMO. Methods. We summarize the rationale of PLEX in relation with the physiology of NMO, the main technical aspects, and the available studies. Results. PLEX in severe attacks from myelitis or optic neuritis are associated with a better outcome, depending on PLEX delay (“time is cord and eyes”). NMO-IgG status has no influence. Finally, we build up an original concept linking the inner dynamic of the lesion, the timing of PLEX onset and the expected clinical results. Conclusion. PLEX is a safe and efficient add-on therapy in NMO, in synergy with steroids. Large therapeutic trials are required to definitely assess the procedure and define the time opportunity window.
url http://dx.doi.org/10.1155/2012/787630
work_keys_str_mv AT mickaelbonnan plasmaexchangeinsevereattacksofneuromyelitisoptica
AT philippecabre plasmaexchangeinsevereattacksofneuromyelitisoptica
_version_ 1725450776542707712